1.
Cancer survival rates: the CONCORD-2 study
by Wegwarth, Odette
The Lancet (British edition), 2015-08-01, Vol.386 (9992), p.429
2.
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
by Seymour, Lesley, Prof
The lancet oncology, 2017, Vol.18 (3), p.e143-e152
3.
Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study
by Bulten, Wouter
The lancet oncology, 2020-02, Vol.21 (2), p.233-241
4.
Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE)
by Raaschou-Nielsen, Ole, Dr
The lancet oncology, 2013, Vol.14 (9), p.813-822
5.
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer cons...
by Guckenberger, Matthias
The lancet oncology, 2020-01, Vol.21 (1), p.e18-e28
6.
Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a modelling study...
by Simms, Kate T
The lancet oncology, 2019-03, Vol.20 (3), p.394-407
7.
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
by Kather, Jakob Nikolas
Nature medicine, 2019-07, Vol.25 (7), p.1054-+
8.
Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review
by Hamaker, Marije E, Dr
The lancet oncology, 2012, Vol.13 (10), p.e437-e444
9.
Real-time artificial intelligence for detection of upper gastrointestinal cancer by endoscopy: a multicentre, case-control, diagnostic study
by Luo, Huiyan
The lancet oncology, 2019-12, Vol.20 (12), p.1645-1654
10.
Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analys...
by Franko, Jan, Dr
The lancet oncology, 2016, Vol.17 (12), p.1709-1719
11.
Global cancer transitions according to the Human Development Index (2008–2030): a population-based study
by Bray, Freddie, Dr
The lancet oncology, 2012, Vol.13 (8), p.790-801
12.
Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission population-based study
by McPhail, Sean
The lancet oncology, 2022-05-01, Vol.23 (5), p.587
13.
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled...
by Fizazi, Karim, Prof Dr
The lancet oncology, 2012, Vol.13 (10), p.983-992
14.
Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study
by Rumgay, Harriet
The lancet oncology, 2021-08, Vol.22 (8), p.1071-1080
15.
International incidence of childhood cancer, 2001–10: a population-based registry study
by Steliarova-Foucher, Eva, Dr
The lancet oncology, 2017, Vol.18 (6), p.719-731
16.
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrin...
by Cristofanilli, Massimo, Prof
The lancet oncology, 2016, Vol.17 (4), p.425-439
17.
Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study
by Sud, Amit
The lancet oncology, 2020-08, Vol.21 (8), p.1035-1044
18.
Tumor metastasis: moving new biological insights into the clinic
by Wan, Liling
Nature medicine, 2013-11, Vol.19 (11), p.1450-1464
19.
Ki67 in breast cancer: prognostic and predictive potential
by Yerushalmi, Rinat, Dr
The lancet oncology, 2010, Vol.11 (2), p.174-183
20.
The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017
by Force, Lisa M
The lancet oncology, 2019, Vol.20 (9), p.1211-1225
